NORSWITCH Meeting Invites Dialogue on Biosimilar Switching

Share on facebook
Share on twitter
Share on linkedin
As more biosimilars become available globally, clinicians are eager to understand: How does switching between biological medicines affect patients? On June 13, the Global Alliance for Patient Access hosted an international group of physicians, researchers and patient advocates in London to take a closer look at one source of clinical data on switching – the NORSWITCH study.